Patients experiencing cancer face substantial mental health challenges including depression, anxiety, insomnia, and other symptoms, which can have a major impact on quality of life as well as impact continuation with cancer treatment. A shortage of mental health professionals trained in cancer care, coupled with stigma surrounding mental health, cost and logistic burden substantially limit the number of cancer patients who receive optimal care. Blue Note Therapeutics is asking ArtCenter students to help address this need by building and clinically-validating a digital, FDA-approved device which can enable oncologists to prescribe mental health care to their patients in need and to enable healthcare professionals to serve a larger patient population. In order to do so, cancer patients must want to adopt and engage with a digital device for 8-12 weeks to receive the clinical benefit of reduced distress or depression. Taught by Brian Boyl and Jeff Higashi.